The Financial Express1h
Tirzepatide for weight loss: All you need to know
This year, revolutionary anti-obesity drugs Wegovy and Ozempic (manufactured by Danish drugmaker Novo Nordisk), and Eli Lilly ...
ScienceAlert on MSN7h
Scientists May Have Discovered a Natural Alternative to Ozempic
Scientists may have identified a way to naturally regulate blood sugar levels and sugar cravings in a similar fashion to ...
The Financial Express3h
Blockbuster weight loss drug Tirzepatide coming to India soon: Benefits, weight loss potential, and side effects
This year, revolutionary anti-obesity drugs Wegovy and Ozempic (manufactured by Danish drugmaker Novo Nordisk), and Eli Lilly ...
Gulfbusiness.com on MSN3h
Mubadala’s KELIX bio acquires Julphar’s DiabTec
DiabTec operates a facility equipped with 20,000-litre drug substance reactors and a separate cartridge fill-finish facility ...
Fin vs Fin on MSN6h
Hims vs Ro: Which Weight Loss Program Fits You Best?
Losing weight can feel like climbing a mountain with no clear path. The one-size-fits-all advice—like “eat less, move ...
Curalife’s ‘Curaslim’ Brings Innovation to the $177 Billion Chronic Wellness Supplement Market
Metabolic healthcare—encompassing conditions such as diabetes, obesity, and hypertension—has become a global health crisis.
Livewire Markets5h
8 stock picks to own for the next 5 years
Amazingly, Jennings was not the only person to call out Tuas as the stock he'd hold for the next five years. 1851 Capital's Chris Stott also nominated Tuas. Like Jennings, he called out David Teoh's ...
Jim Cramer on Merck & Co., Inc. (MRK): ‘Right Now, The Stock’s Well-ensconced A Few Points Around 52-week Low’
We recently compiled a list of the 9 Stocks on Jim Cramer’s Radar. In this article, we are going to take a look at where Merck & Co., Inc.